Wat is CYP3A4?
The CYP3A4 gene is responsible for producing the most versatile and important enzyme in the human liver. This enzyme is often referred to as the “workhorse” of drug metabolism because it is involved in breaking down approximately 50% of all medications prescribed worldwide. Unlike temporary biomarkers, your CYP3A4 status is genetically determined and unchanging; it serves as the blueprint for how your body responds to a wide range of therapies throughout your entire life.
The gene determines whether your body breaks down medication at the intended rate. Because CYP3A4 is involved with so many substances, a genetic variation in this enzyme directly impacts the safety and effectiveness of numerous treatments.
Why test your CYP3A4 status?
Given the vast number of medications processed by CYP3A4, abnormal enzyme activity can have significant consequences for your health:
- Preventing severe side effects: With slow enzyme activity, medication accumulates in your blood. This can lead to toxicity and side effects, even at a “normal” dosage that is safe for others.
- Ensuring effectiveness: With an overactive enzyme, the active substance is broken down so quickly that blood levels remain too low to be effective. Consequently, the treatment simply fails to work.
- Insight into complex interactions: Because CYP3A4 is involved in so many substances, a DNA test helps your doctor understand why you may react strongly to drug combinations or even certain foods (such as grapefruit juice).
Medications influenced by CYP3A4
The list of medications dependent on CYP3A4 is extensive. A pharmacogenetic passport is essential for these groups:
- Cholesterol-lowering drugs (Statins): including Simvastatin and Atorvastatin.
- Blood pressure medications: including Amlodipine, Felodipine, and Nifedipine.
- Immunosuppressants: including Tacrolimus and Cyclosporine (crucial for transplants).
- Sleep and sedative medications: including Midazolam and Triazolam.
- Oncology: various forms of chemotherapy and targeted therapy.
- Painkillers: including Fentanyl.
Interpretation of your CYP3A4 status
Based on your DNA profile, you are classified into one of four metabolism types. This determines the optimal treatment strategy for the mentioned medications:
| Result | Interpretatie | Interpretation |
|---|---|---|
| PM | Poor Metabolizer (Non-expressor) | The enzyme is inactive. This is the case for most Europeans. You have an increased risk of side effects with standard doses of specific medications. |
| IM | Intermediate Metabolizer | The enzyme exhibits limited activity. Medication processing is slower than average, often requiring careful dosing. |
| NM | Normal Metabolizer (Expressor) | The enzyme is active and functioning normally. Certain medications (such as tacrolimus) are broken down more quickly, so a higher dose is often required for effectiveness. |
| UM | Ultrarapid Metabolizer | The enzyme works extremely quickly. Medication is removed from the body very quickly, which increases the risk of insufficient effectiveness of the therapy. |
Medical interpretation & advice
Your test results from Easly are cross-referenced with the official medication guidelines of the KNMP (G-Standard). This provides you, your pharmacist, and your doctor with a scientific foundation for a personalized treatment plan.
Important: Always use this result in consultation with your treating physician or pharmacist. Never adjust your dosage independently. Based on your profile, a doctor or pharmacist may decide to optimize the dose or switch to a medication that does not depend on this specific enzyme.
Don’t keep struggling with unexplained side effects.
Do you want to know if your symptoms can be explained by your DNA profile? Take the free Pharmacogenetic Quickscan (Only available in Dutch) and get immediate clarity on whether a test is right for you.
